Jinyu Bio-Technology Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.65%

Jinyu Bio-Technology Co Ltd (600201) has an Asset Resilience Ratio of 0.65% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 600201 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥43.60 Million

≈ $6.38 Million USD Cash + Short-term Investments

Total Assets

CN¥6.73 Billion

≈ $985.46 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Jinyu Bio-Technology Co Ltd's Asset Resilience Ratio has changed over time. See Jinyu Bio-Technology Co Ltd (600201) shareholders funds for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Jinyu Bio-Technology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Jinyu Bio-Technology Co Ltd worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥43.60 Million	0.65%
Total Liquid Assets	CN¥43.60 Million	0.65%

Asset Resilience Insights

Limited Liquidity: Jinyu Bio-Technology Co Ltd maintains only 0.65% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Jinyu Bio-Technology Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jinyu Bio-Technology Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	3.28%
Ascendis Pharma AS F:A71	Biotechnology	0.00%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	0.00%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Sinopep-Allsino Biopharmaceutical Co. Ltd. A SHG:688076	Biotechnology	1.39%
Wuhan Keqian Biology Co Ltd SHG:688526	Biotechnology	19.42%
R&G PharmaStudies Co. Ltd. A SHE:301333	Biotechnology	35.96%
Shanghai Shen Lian Biomedical Corp SHG:688098	Biotechnology	3.87%

Annual Asset Resilience Ratio for Jinyu Bio-Technology Co Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Jinyu Bio-Technology Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.54%	CN¥36.83 Million ≈ $5.39 Million	CN¥6.76 Billion ≈ $989.88 Million	+0.00pp
2023-12-31	0.54%	CN¥37.27 Million ≈ $5.45 Million	CN¥6.87 Billion ≈ $1.01 Billion	-0.19pp
2022-12-31	0.73%	CN¥46.94 Million ≈ $6.87 Million	CN¥6.39 Billion ≈ $934.96 Million	-2.05pp
2021-12-31	2.78%	CN¥183.85 Million ≈ $26.90 Million	CN¥6.60 Billion ≈ $966.36 Million	-7.40pp
2020-12-31	10.19%	CN¥639.48 Million ≈ $93.58 Million	CN¥6.28 Billion ≈ $918.71 Million	-1.85pp
2019-12-31	12.04%	CN¥672.48 Million ≈ $98.40 Million	CN¥5.59 Billion ≈ $817.39 Million	-0.63pp
2018-12-31	12.67%	CN¥800.00 Million ≈ $117.07 Million	CN¥6.31 Billion ≈ $923.82 Million	-1.40pp
2017-12-31	14.08%	CN¥800.00 Million ≈ $117.07 Million	CN¥5.68 Billion ≈ $831.69 Million	+8.05pp
2016-12-31	6.03%	CN¥262.00 Million ≈ $38.34 Million	CN¥4.35 Billion ≈ $636.21 Million	--

pp = percentage points

About Jinyu Bio-Technology Co Ltd

SHG:600201 China Biotechnology

Market Cap

$2.37 Billion

CN¥16.22 Billion CNY

Market Cap Rank

#5654 Global

#1163 in China

Share Price

CN¥14.59

Change (1 day)

+3.99%

52-Week Range

CN¥6.95 - CN¥18.78

All Time High

CN¥30.02